Skip to main content

Rakovina Therapeutics Inc(RKV-X)
TSX Venture

Today's Change
Delayed Last Update

Rakovina Therapeutics Inc

8 Smithe Mews
Suite 2201
Vancouver BC V6B 0A5 CAN
P: 403-613-1453
https://www.rakovinatherapeutics.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some f its products in the pipeline include kt-2000 Next Generation PARP-inhibitors, kt-3000 Dual Action DDR-inhibitors, and kt-4000 DNA Damaging DDR-inhibitors.

    Key Executives

    NameTitle
    Mads DaugaardCEO/Chief Scientific Officer/President
    John LanglandsCOO
    David HymanCFO/Secretary

    More from The Globe